CVE-2024-41107: Apache CloudStack: SAML Signature Exclusion
Apache Software Foundation · Apache CloudStack
Vendor fix available · Affected: Apache Software Foundation Apache CloudStack · Exploitation: check available, not yet exploited
Not in CyberSIXT coverage yet: no article names this CVE. This page shows the public record.
Higher than 97% of scored CVEs
DescriptionCVE.org
The CloudStack SAML authentication (disabled by default) does not enforce signature check. In CloudStack environments where SAML authentication is enabled, an attacker that initiates CloudStack SAML single sign-on authentication can bypass SAML authentication by submitting a spoofed SAML response with no signature and known or guessed username and other user details of a SAML-enabled CloudStack user-account. In such environments, this can result in a complete compromise of the resources owned and/or accessible by a SAML enabled user-account. Affected users are recommended to disable the SAML authentication plugin by setting the "saml2.enabled" global setting to "false", or upgrade to version 4.18.2.2, 4.19.1.0 or later, which addresses this issue.
Affected products1
From the CVE record. A product or version that is not listed is unknown, not unaffected.
- Apache Software Foundation · Apache CloudStackfrom 4.5.0 up to and including 4.18.2.1; from 4.19.0.0 up to and including 4.19.0.2
On the Atlas
Every published CVE is on the CyberSIXT Atlas, grouped by weakness, vendor and month.
- Exploitation
- Check available, not yet exploited. A public nuclei template can confirm it on a system you are authorised to test.
- CISA KEV
- Not listed
- Public check
- Apache CloudStack - SAML Signature Exclusion · nuclei template in projectdiscovery/nuclei-templates
- Published
- July 2024
CoverageNo articles yet
No CyberSIXT article names CVE-2024-41107 yet, so there is no coverage timeline, action brief or change log for it. Everything on this page comes from the public CVE record, CISA KEV, EPSS and the nuclei template index. Search the archive or see the CVEs in the news.